Blog

9 February, 2026

Artificial intelligence enables more accurate stratification of breast cancer risk

An artificial intelligence model trained solely on mammography images demonstrates greater accuracy than breast density in estimating five-year breast cancer risk, paving the way for more […]
5 February, 2026

From potential to results: how pharmaceutical companies measure the impact of AI on their forecasts

elglobalfarma.com The global pharmaceutical industry is undergoing a quiet but profound transformation in the way it anticipates the future. A new report on forecasting and artificial […]
3 February, 2026

The ‘Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy’, recognized with the Diagnosis Award

The project, promoted by the Spanish Society of Hospital Pharmacy, the General Council of Pharmacists, and Farmaindustria, has won the award for Best Pharmaceutical Initiative at […]
29 January, 2026

Artificial intelligence accelerates drug development, but has yet to discover the miracle molecule

Although AI has not yet achieved major medical advances on its own, the industry already uses it to save time and costs and speed up trials. […]
27 January, 2026

GEPAC and Farmaindustria sign an agreement to promote research, access to innovation, and the measurement of health outcomes in oncology

Both entities are committed to promoting activities that raise awareness of patient associations in Spain, with a special focus on organizations linked to oncology. Begoña Barragán, […]
27 January, 2026

The pharmaceutical industry values the ten commandments of good practice in the use of AI in drug development, drawn up by the EMA and the FDA.

Both regulatory agencies recognize the potential of this technology to transform biomedical innovation and hope to help lay the groundwork for joint work among stakeholders in […]
20 January, 2026

Spain once again leads clinical trials in Europe, but faces the challenge of competing in the global biomedical race

Our country authorized 962 studies last year, a hundred more than in 2023. Four out of every 10 research projects were dedicated to finding new cancer […]
14 January, 2026

Spain leads clinical research in the EU: 962 trials authorized and record administrative agility

The Spanish Registry of Clinical Studies points out that the country’s excellent hospital network and regulatory efficiency make it a strategic destination for the development of […]
13 January, 2026

Sustainability, yes; efficiency and competitiveness, too

expansion.com Companies and associations discussed how an appropriate sustainability strategy can help organizations become more competitive and attract talent and investment. Companies that already integrate ESG […]
13 January, 2026

The geopolitical context presents Spain with a great opportunity to attract investment in the biopharmaceutical sector.

A new report by Analistas Financieros Internacionales (AFi) highlights the sector’s potential to become a global hub for innovation and drug production. Farmaindustria has presented seven […]
8 January, 2026

Patient engagement and efficiency in clinical trials: an opportunity the industry cannot ignore

A qualitative study reveals that early and meaningful patient involvement improves the quality, ethics and efficiency of pharmaceutical research. consalud.es Patient involvement in clinical research and […]
16 December, 2025

The reform of EU pharmaceutical legislation, insufficient to maintain competitiveness with the US and Asia

The package recognises the strategic importance of medicines for health and the economy, but it lacks ambition and concrete measures to halt the loss of leadership […]
16 December, 2025

Europe has the potential to be a leader in the research, development and production of new medicines.

Europe must make a decision Europe has the potential to be a leader in the research, development and production of new medicines. Geopolitical changes are transforming […]
11 December, 2025

Clinical trials reach patients through primary care

Experts, administrations and industry agree that primary care is key to democratising access to drug trials and addressing the challenges facing the healthcare system. Text: Anna […]
10 December, 2025

The first fast track for multinational clinical trials in Europe will start in January 2026 and will help strengthen European competitiveness in this area.

The Spanish Agency for Medicines and Health Products has been one of the driving forces behind this accelerated assessment procedure, which will provide trial sponsors with […]
2 December, 2025

Spain takes a key step forward with the new Regional Map and Observatory for Clinical Research in Primary Care

Both initiatives are a step forward in raising awareness of regional efforts to make clinical trials in health centres a common reality in our country. Clinical […]
19 November, 2025

Adaptive clinical trials, a key element in transforming vaccine development globally

A comprehensive analysis reveals how these designs improve efficiency, streamline regulatory decision-making, and strengthen pandemic preparedness. consalud.es The rise of adaptive clinical trials represents a profound […]
12 November, 2025

‘Bringing science closer to schools’: a decade of training young people in clinical research and inspiring vocations

Ten years ago, the Sant Joan de Déu Research Institute and Farmaindustria launched this project, which has reached more than 3,000 sixth form and vocational training […]
10 November, 2025

“Distefar, highly conscious of the environment, welcomes and echoes the environmental transformation that the pharmaceutical industry is undergoing towards sustainability.”

The goal of net zero emissions is a global commitment shared by many industries, including pharmaceuticals. However, the path to true sustainability goes beyond simple regulatory […]
5 November, 2025

The smart medicine revolution is reshaping the global pharmaceutical market

Advances in nanotechnology, biosensors, and artificial intelligence are redefining drug delivery, with a growing impact on therapeutic efficacy, patient adherence, and global pharmaceutical development. Consalud.es For […]
30 October, 2025

A study of stem cells opens the door to regenerating the brain after a stroke

A team from the University of Zurich demonstrates in mice that neural stem cell transplantation regenerates neurons, restores motor functions and opens up a path of […]
29 October, 2025

US tariffs threaten European pharmaceutical industry: its value could fall by up to 5%

A SUERF report warns that the tariffs imposed by Washington in 2025 will particularly affect the pharmaceutical sector in Europe, hitting countries such as Ireland, Belgium […]
27 October, 2025

Global Clinical Trials Forum: ‘Only those that are ethical, high-quality and inclusive will thrive’

The World Health Organisation explains in an interview with ConSalud.es that the recently launched Global Clinical Trials Forum seeks to combat fragmentation and barriers in research. […]
21 October, 2025

The geopolitical context presents Spain with a great opportunity to attract investment in the biopharmaceutical sector.

A new report by Analistas Financieros Internacionales (AFi) highlights the sector’s potential to become a global hub for innovation and drug production. Farmaindustria has presented seven […]
14 October, 2025

“Spain has a great opportunity in the biopharmaceutical sector, but it must review its policies to maintain and increase its potential and attract investment in R&D and in industrial and digital assets.”

The president of Farmaindustria, Fina Lladós, calls for a regulatory framework that improves the country’s competitiveness in order to turn the current situation of global uncertainty […]
7 October, 2025

Spain consolidates its leadership in clinical trials with new guidelines promoting innovation, digitalisation and sustainability in hospital pharmacy

Pharmacists and industry present the updated “Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy” in Barcelona. This is another step towards excellence and improving […]
2 October, 2025

Innovation and data at the service of clinical research

Our Director of Clinical and Translational Research, Amelia Martín Uranga, participated on Wednesday in Innodata 2025, a national conference on innovation through the use of health […]
30 September, 2025

Spain, European leader in clinical trials against cancer thanks to the agility and ‘atomisation’ of research groups

20minutos.es Spain is bucking the general decline in cancer clinical trials seen across Europe: it is the only country maintaining its level of research, compared to […]
24 September, 2025

Advanced therapies in lymphoma: six years of CAR-T that have changed patients’ lives

Gilead held the 6th Advanced Therapies Meeting to celebrate therapeutic advances in the treatment of lymphoma. consalud.es Advanced therapies are transforming the way we understand and […]
17 September, 2025

The Community of Madrid aspires to become the “Silicon Valley” of the pharmaceutical sector.

Madrid launches a pioneering strategy to become a global benchmark in biopharmaceutical innovation. consalud.es On Monday, the Community of Madrid presented its 2025-2028 Sector Strategy to […]
28 January, 2020

Clinical trials, cost savings for the system and innovative therapies for the patient

They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]